Mawson Infrastructure Group Inc. — Director's Dealing 2018

Jan 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-01-18

Reporting Person: Zarachia Yaakov (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-18	Common Stock, par value $0.001 per share	P	5000	$0.12	Acquired	12371892	Direct